MELTF and nonpapillary renal cell carcinoma: A study of seven lncRNAs with prognostic value found that risk signals including MELTF-AS1 can be used as prognostic indicators in patients with clear cell renal cell carcinoma (ccRCC), and may serve as potential prognostic biomarkers [28].